Secreted Frizzled-Related Protein 4 Reduces Insulin Secretion and Is Overexpressed in Type 2 Diabetes

A plethora of candidate genes have been identified for complex polygenic disorders, but the underlying disease mechanisms remain largely unknown. We explored the pathophysiology of type 2 diabetes (T2D) by analyzing global gene expression in human pancreatic islets. A group of coexpressed genes (mod...

Full description

Saved in:
Bibliographic Details
Published inCell metabolism Vol. 16; no. 5; pp. 625 - 633
Main Authors Mahdi, Taman, Hänzelmann, Sonja, Salehi, Albert, Muhammed, Sarheed J., Reinbothe, Thomas M., Tang, Yunzhao, Axelsson, Annika S., Zhou, Yuedan, Jing, Xingjun, Almgren, Peter, Krus, Ulrika, Taneera, Jalal, Blom, Anna M., Lyssenko, Valeriya, Esguerra, Jonathan Lou S., Hansson, Ola, Eliasson, Lena, Derry, Jonathan, Zhang, Enming, Wollheim, Claes B., Groop, Leif, Renström, Erik, Rosengren, Anders H.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 07.11.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A plethora of candidate genes have been identified for complex polygenic disorders, but the underlying disease mechanisms remain largely unknown. We explored the pathophysiology of type 2 diabetes (T2D) by analyzing global gene expression in human pancreatic islets. A group of coexpressed genes (module), enriched for interleukin-1-related genes, was associated with T2D and reduced insulin secretion. One of the module genes that was highly overexpressed in islets from T2D patients is SFRP4, which encodes secreted frizzled-related protein 4. SFRP4 expression correlated with inflammatory markers, and its release from islets was stimulated by interleukin-1β. Elevated systemic SFRP4 caused reduced glucose tolerance through decreased islet expression of Ca2+ channels and suppressed insulin exocytosis. SFRP4 thus provides a link between islet inflammation and impaired insulin secretion. Moreover, the protein was increased in serum from T2D patients several years before the diagnosis, suggesting that SFRP4 could be a potential biomarker for islet dysfunction in T2D. [Display omitted] ▸ SFRP4 is a hub gene in a T2D-associated gene coexpression module in human islets ▸ SFRP4 reduces glucose-induced insulin secretion through decreased β cell exocytosis ▸ Expression and release of SFRP4 from islets is enhanced by interleukin-1β ▸ SFRP4 is elevated in serum several years before clinical diagnosis of T2D
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1550-4131
1932-7420
DOI:10.1016/j.cmet.2012.10.009